Delivery Order SPE2DB20D3103-SPE2DB25FQ1G3
- Not listed
- The Defense Logistics Agency (DLA) awarded a $35,881.26 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with performance completion targeted for September 9, 2025. This non-competitive delivery order employs firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml, a specialty pharmaceutical product. This firm fixed price delivery order, with a completion date of September 9, 2025, represents a non-competitive, non-set-aside award for a critical oncology medication supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $59,802.10 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Darzalex FasPro 1,800mg-30,000 15ml pharmaceutical product. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating the award was made through open...
- The Defense Logistics Agency awarded a $23,920.84 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. The order, with an ultimate completion date of September 24, 2025, represents a non-set-aside competitive award supporting federal medical procurement requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $23,920.84, represents a non-competitive set-aside transaction and is set to conclude by September 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the federal government's medical supply chain...
- The Defense Logistics Agency awarded a $17,940.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product on August 25, 2025, with an ultimate completion date of September 16, 2025. This is a non-set-aside competitive award with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $478,416.80 to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products. This firm fixed price delivery order, awarded on September 2, 2025, represents a non-competitive, competitively awarded procurement with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This non-set-aside, competitively awarded delivery order carries a ceiling value of $95,683.36 under a firm fixed price contract type, with an ultimate completion date of August 29, 2025. The award was made on August 8, 2025, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at approximately $59.8K to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg/30,000 15ml pharmaceutical product. This firm fixed-price, non-set-aside contract is scheduled for completion by September 5, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $23,920.84 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania by August 18, 2025. This competitive award, issued under a firm fixed-price delivery order contract with no set-aside designation, represents a single transaction on AmerisourceBergen's larger pharmaceutical supply agreement with the agency. This delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ1G3Delivery Order
The Defense Logistics Agency awarded a $35,881.26 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 (15ml units), a pharmaceutical product used in cancer treatment. This firm fixed-price delivery order, which must be completed by September 24, 2025, carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's medical supply chain. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's contract portfolio demonstrates consistent capability to fulfill federal medical supply requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.9k | 9/3/25 |